The authors describe the characterization of polymers and additives using a novel heart-cut evolved gas analysis GC–MS method.
Guest authors discuss equipment qualification for good laboratory and manufacturing practices compliance.
Guest authors discuss equipment qualification for good laboratory and manufacturing practices compliance.
The author describes using HPLC with chemiluminescence nitrogen-specific detection and aperometric detection to determine organic impurities in a tedisamil dihydrochloride drug substance.
The authors describe the characterization of polymers and additives using a novel heart-cut evolved gas analysis GC–MS method.
The authors evaluate the performance of multiplexed 96-lane CE with laser-induced fluorescence detection for high-throughput separation–based assays using fluorescein isothiocyanate as a model compound and fluorescein as an internal standard.
The authors evaluate the performance of multiplexed 96-lane CE with laser-induced fluorescence detection for high-throughput separation–based assays using fluorescein isothiocyanate as a model compound and fluorescein as an internal standard.
The authors evaluate the performance of multiplexed 96-lane CE with laser-induced fluorescence detection for high-throughput separation–based assays using fluorescein isothiocyanate as a model compound and fluorescein as an internal standard.
The authors evaluate the performance of multiplexed 96-lane CE with laser-induced fluorescence detection for high-throughput separation–based assays using fluorescein isothiocyanate as a model compound and fluorescein as an internal standard.
The authors evaluate the performance of multiplexed 96-lane CE with laser-induced fluorescence detection for high-throughput separation–based assays using fluorescein isothiocyanate as a model compound and fluorescein as an internal standard.
Guest authors describe how this validation is performed routinely in their laboratory.
The authors present their observations from developing data-handling software for GC × GC separations.
Guest author Steve Griffin identifies the fundamental problems in capillary manufacturing techniques that cause capillary defects and suggests some corrective actions.
Guest authors describe how this validation is performed routinely in their laboratory.
Guest authors describe how this validation is performed routinely in their laboratory.
Guest authors describe how this validation is performed routinely in their laboratory.
Guest authors describe how this validation is performed routinely in their laboratory.
This article provides theoretical background, experimental data, and practical considerations about the effects of organic modifiers on analyte ionization in reversed-phase LC.
The authors studied the retention behavior of reversed-phase HPLC columns under 100% aqueous mobile-phase conditions.
The authors studied the retention behavior of reversed-phase HPLC columns under 100% aqueous mobile-phase conditions.
This article provides theoretical background, experimental data, and practical considerations about the effects of organic modifiers on analyte ionization in reversed-phase LC.
The authors studied the retention behavior of reversed-phase HPLC columns under 100% aqueous mobile-phase conditions.
IMS is a valuable tool for biopharmaceutical analysis. Two formats in particular have proven useful: cyclic IMS and structures for lossless manipulations (SLIM).
The guest authors present a strategy for validating a capillary isoelectric focusing method intended to quantitate impurities in a protein drug substance.
The guest authors present a strategy for validating a capillary isoelectric focusing method intended to quantitate impurities in a protein drug substance.
This article examines the role that multidimensional chromatography systems will play in high-throughput proteomics.
Part II of this series describes different ways electrolytes can be buffered while maintaining compatibility with indirect detection.
Part II of this series describes different ways electrolytes can be buffered while maintaining compatibility with indirect detection.
The FDA recently updated its 1987 guidelines for submitting samples and analytical data for method validation — a document that affects all analytical chemists working in the pharmacrutical industry. This article highlights the agency's recommendations of how to report and validate analytical data in all new drug applications.
The FDA recently updated its 1987 guidelines for submitting samples and analytical data for method validation — a document that affects all analytical chemists working in the pharmacrutical industry. This article highlights the agency's recommendations of how to report and validate analytical data in all new drug applications.